about
Roles of CD4 and coreceptors in binding, endocytosis, and proteolysis of gp120 envelope glycoproteins derived from human immunodeficiency virus type 1The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIVDC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in transSelective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusionAnti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides.Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120HIV: cell binding and entryAn 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cellsClinical significance of HIV-1 coreceptor usage.HIV entry inhibitors: mechanisms of action and resistance pathwaysAccess denied? The status of co-receptor inhibition to counter HIV entryPMS-601, a new platelet-activating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophagesSubstance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytesHuman alpha1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophagesStructural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usageEffects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergismRecent Insights into the HIV/AIDS Pandemic.Getting to know HIV.Potential mechanisms for increased HIV-1 transmission across the endocervical epithelium during C. trachomatis infection.Optical trapping of individual human immunodeficiency viruses in culture fluid reveals heterogeneity with single-molecule resolution.The combination of phylogenetic analysis with epidemiological and serological data to track HIV-1 transmission in a sexual transmission case.Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropismA novel cyclic peptide immunization strategy for preventing HIV-1/AIDS infection and progression.Statins disrupt CCR5 and RANTES expression levels in CD4(+) T lymphocytes in vitro and preferentially decrease infection of R5 versus X4 HIV-1Net positive charge of HIV-1 CRF01_AE V3 sequence regulates viral sensitivity to humoral immunity.Selective transmission of R5 HIV-1 over X4 HIV-1 at the dendritic cell-T cell infectious synapse is determined by the T cell activation state.Different tempo and anatomic location of dual-tropic and X4 virus emergence in a model of R5 simian-human immunodeficiency virus infection.Alcohol potentiates HIV-1 infection of human blood mononuclear phagocytes.Host and viral genetic correlates of clinical definitions of HIV-1 disease progression.Current concepts in human immunodeficiency virus infection and AIDSHIV coreceptors, cell tropism and inhibition by chemokine receptor ligands.Human immunodeficiency virus type 1 entry and chemokine receptors: a new therapeutic target.Identification of CXCR4 domains that support coreceptor and chemokine receptor functionsWill multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants.Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication.Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strainsRole of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism.Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation
P2860
Q22003751-24BC9F6C-52BD-4233-9887-C1474E048E12Q22066237-3115E56C-3040-4307-86A2-543DDAEB51D0Q24601035-22BDC546-3AE1-4881-AC79-9286D7644187Q24673389-86F50978-0D6E-44FE-A8F6-28B08CC412D3Q24678540-E43768BC-EA7D-42C6-A222-58A37F24AD1CQ24794033-CC3D91B5-3BB5-42BF-90F9-91318330B5D8Q24806134-CE9AC4CA-83AC-4C4D-A842-CEB606100A65Q27008983-CD81107B-2E49-429C-84BB-C1FB32FF9B73Q27477568-30877C37-F654-46D1-9895-7FB3411DFD42Q27691426-16D0A01B-7124-4E1B-ACCA-B00BC1C02E7AQ28296162-794B982E-79A9-4709-8703-4D96EC41BCDEQ28300187-BC99CF0A-C153-4200-9FF9-C798C6920F2CQ28344867-7552567F-9964-435E-8066-BF32182EAE53Q28361559-0090347B-306E-462F-9688-24D5CD33F3E0Q28364255-204DDDEA-9252-49E6-8B20-77BE53A16165Q28469177-D637B0F4-C74E-4BAC-9DB5-B5915BC196B7Q28660034-D903727F-04EA-494F-A62C-E9AA0B772E84Q30235024-73D88862-5FB9-40BF-9C62-ACDEA9FFFCF6Q30327142-06013688-E817-4D13-B68A-46ADE78B441CQ30413754-3137F54F-8EDF-4AB9-8A0C-0A240523713CQ30586117-7D14C8BF-F72D-4688-A4BA-ED8BAE6CD261Q30915825-07A831D4-7994-4D12-8689-067F15B81821Q31026698-BB4BDE5C-266D-460D-BD29-A0A4DC2EF2A7Q31143676-E7A38FDB-EA38-4D15-9AD4-381D1DA453C3Q33285482-7950800F-8C66-404E-91C0-B04BBBAC9CCDQ33369086-FC5F61AD-D696-4B42-B105-7F9CCBBE35F5Q33404066-318048F1-079B-4776-8FD2-D51A4E36201DQ33558676-E5D5FFD1-696F-4357-A7EA-922F2595DC37Q33586479-99A12968-A95D-489F-A91D-C8C68AC8E9B7Q33605758-1CFCB535-840A-448B-A29F-A3149404A795Q33606809-6587DFF9-21EC-467F-84AC-0A3D285E39CFQ33637941-81EEF1D8-E06B-42E2-AAAF-1A8322869940Q33639712-B10387F3-BC57-4E66-952F-5B6262F9FCD9Q33643223-C55A03ED-2037-4CE1-9A80-D0C196F19C08Q33645423-0F822B7A-7106-46FA-AA13-1BB0FCAAAF5BQ33645828-112C7F63-D6BF-47B2-AE0D-C1C8E321D5FAQ33646045-9E239D12-7B2E-4757-8CC0-DE5D52CDAE34Q33647409-D561523D-CD10-4FDA-95BA-26C1742FBC81Q33648601-A5378852-4971-4298-BAED-05B957700996Q33649801-486974E7-4F11-4498-9FEE-73764BD33FBC
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
A new classification for HIV-1
@ast
A new classification for HIV-1
@en
A new classification for HIV-1
@en-gb
A new classification for HIV-1
@nl
type
label
A new classification for HIV-1
@ast
A new classification for HIV-1
@en
A new classification for HIV-1
@en-gb
A new classification for HIV-1
@nl
prefLabel
A new classification for HIV-1
@ast
A new classification for HIV-1
@en
A new classification for HIV-1
@en-gb
A new classification for HIV-1
@nl
P2093
P2860
P50
P356
P1433
P1476
A new classification for HIV-1
@en
P2093
Littman DR
Sattentau QJ
Schuitemaker H
P2860
P2888
P356
10.1038/34571
P407
P577
1998-01-01T00:00:00Z
P6179
1042683516